Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MENS stock hub

Jyong Biotech Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MENSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

157.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MENS

In the news

Latest news · MENS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MENS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

131

Groups with data

Currency

USD

Showing 131 of 131 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001954488
Company name	Jyong Biotech Ltd.
Country	Taiwan
Country code	US
Cusip	G83116106
Employees Change	0%
Employees Change Percent	0
Enterprise value	$175.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-06-17
Isin	KYG831161065
Last refreshed	2026-05-10
Market cap	$157.6M
Market cap category	Micro-Cap
Price	$2.05
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	MENS
Website	https://jyongbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.87%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-2.9M
ROA	-5.44
ROCE	-18.99

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$37.7M
Cash	$17M
Current Assets	$17.2M
Current Liabilities	$27.6M
Debt	$35.2M
Equity	$-22.5M
Interest Coverage	-1.91
Liabilities	$60.1M
Long Term Assets	$20.5M
Long Term Liabilities	$32.6M
Net Cash	$-18.2M
Net Cash By Market Cap	$-11.54
Tangible Book Value	$-22.5M
Tangible Book Value Per Share	$-0.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.62
Net Working Capital	$-4.5M
Quick ratio	0.62
Working Capital	$-10.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.13%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	23.09
50-day SMA	2.21
50-day SMA vs 200-day SMA	50under200
All Time High	67
All Time High Change	-96.95%
All Time High Date	2025-09-12
All Time Low	1.43
All Time Low Change	43.13%
All Time Low Date	2026-02-11
ATR	0.2
Beta1y	3.32
Ch YTD	-48.18
High	2.1
High52	67
High52 Date	2025-09-19
High52ch	-96.95%
Low	2
Low52	1.43
Low52 Date	2026-02-11
Low52ch	43.13%
Ma50ch	-7.55%
Price vs 200-day SMA	-91.13%
RSI	41.17
RSI Monthly	0
RSI Weekly	35.56
Sharpe ratio	0.24x
Sortino ratio	0.38
Total Return	-0.13%
Tr YTD	-48.18
Tr1m	-19.1%
Tr1w	-9.03%
Tr3m	9.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-1.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,608,218%
Float Percent	38.5%
Shares Insiders	61.5%
Shares Institutions	0.97%
Shares Out	76,900,076
Shares Qo Q	0.27%
Shares Yo Y	0.13%
Short Float	0.45%
Short Ratio	0.76
Short Shares	0.17

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	86,426.6x
Bv Per Share	-0.31
Ch1m	-19.1
Ch1w	-9.03
Ch3m	9.46
Ch6m	-94.73
Change	-0.16%
Change From Open	-2.07
Close	2.05
Days Gap	1.95
Depreciation Amortization	118,000
Dollar Volume	80,435.1
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-1.9M
EBITDA	$-1.8M
EPS	$-0.04
F Score	1
Fiscal Year End	December
Founded	2,002
Iprfo	-86.35
Is Primary Listing	1
Is Spac	No
Last Report Date	2025-06-30
Last Split Type	Never
Ma150	15.82
Ma150ch	-87.06%
Ma20	2.29
Ma20ch	-10.54%
Next Earnings Date	2026-05-22
Open	2.09
Optionable	Yes
Position In Range	45.8
Post Close	2.05
Postmarket Change Percent	0.16
Postmarket Price	$2.05
Ppne	3,452,000
Price Date	2026-05-08
Relative Volume	0.45x
Tr6m	-94.73%
Volume	39,298

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MENS pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns MENS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Float: +38.5% of shares outstanding

Insider ownership

+61.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MENS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.2

Neutral momentum band

Price vs 200-day MA

-91.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MENS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MENS stock rating?

Jyong Biotech Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MENS analysis?

The full report lives at /stocks/MENS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MENS?

The latest report frames MENS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MENS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.